APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Organs-on-Chips

An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.

The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).

In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.

Selected research

Market Outlook & Growth Opportunities

Global Human Organs-on-Chips Market Outlook and Growth Opportunities 2026

29 December 2025191 pages

Choose your research edition.

Industry ResearchHuman Organs-on-Chips Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Organs-on-Chips Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Human Organs-on-Chips Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Organs-on-Chips Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Organs-on-Chips Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.

The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).

In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.

Read the full market overview

Global key players of Human Organs-on-Chips include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems and Draper Laboratory, etc. Top five players occupy for a share about 46%. North America is the largest market, with a share about 42%, followed by Asia-Pacific and Europe. In terms of product, Liver-on-a-chip is the largest segment, with a share over 28%. In terms of End User, Academic & Research Institutes is the largest market, with a share over 40%.

This report provides an overview of the global Human Organs-on-Chips market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Organs-on-Chips and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Organs-on-Chips sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Organs-on-Chips market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Organs-on-Chips Segment by Company

Emulate

TissUse

Hesperos

CN Bio Innovations

Tara Biosystems

Draper Laboratory

Mimetas

Nortis

Micronit Microtechnologies B.V.

Kirkstall

Cherry Biotech SAS

Else Kooi Laboratory

Human Organs-on-Chips Segment by Type

Brain-on-a-chip

Liver-on-a-chip

Kidney-on-a-chip

Lung-on-a-chip

Heart-on-a-chip

Intestine-on-a-chip

Vessel-on-a-chip

Other Organs

Human Organs-on-Chips Segment by End User

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Cosmetics Industry

Others

Human Organs-on-Chips Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Human Organs-on-Chips status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Human Organs-on-Chips market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Human Organs-on-Chips significant trends, drivers, influence factors in global and regions.

6. To analyze Human Organs-on-Chips competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Organs-on-Chips market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Organs-on-Chips and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Organs-on-Chips.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Organs-on-Chips market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Organs-on-Chips industry.

Chapter 3: Detailed analysis of Human Organs-on-Chips manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Human Organs-on-Chips in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Human Organs-on-Chips in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Human Organs-on-Chips Industry Trends Table 2. Human Organs-on-Chips Industry Drivers Table 3. Human Organs-on-Chips Industry Opportunities and Challenges Table 4. Human Organs-on-Chips Industry Restraints Table 5. Global Human Organs-on-Chips Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Human Organs-on-Chips Revenue Share by Company (2021-2026) Table 7. Global Human Organs-on-Chips Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Human Organs-on-Chips Sales Volume Share by Company (2021-2026) Table 9. Global Human Organs-on-Chips Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Human Organs-on-Chips Company Ranking, (2024-2026) & (USD Million) Table 11. Global Human Organs-on-Chips Key Company Manufacturing Base & Headquarters Table 12. Global Human Organs-on-Chips Company, Product Type & Application Table 13. Global Human Organs-on-Chips Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Organs-on-Chips by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Brain-on-a-chip Table 18. Significant Companies of Liver-on-a-chip Table 19. Significant Companies of Kidney-on-a-chip Table 20. Significant Companies of Lung-on-a-chip Table 21. Significant Companies of Heart-on-a-chip Table 22. Significant Companies of Intestine-on-a-chip Table 23. Significant Companies of Vessel-on-a-chip Table 24. Significant Companies of Other Organs Table 25. Global Human Organs-on-Chips Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Human Organs-on-Chips Sales Volume by Type (2021-2026) & (K Units) Table 27. Global Human Organs-on-Chips Sales Volume by Type (2027-2032) & (K Units) Table 28. Global Human Organs-on-Chips Sales Volume Share by Type (2021-2026) Table 29. Global Human Organs-on-Chips Sales Volume Share by Type (2027-2032) Table 30. Global Human Organs-on-Chips Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Human Organs-on-Chips Sales Value by Type (2021-2026) & (US$ Million) Table 32. Global Human Organs-on-Chips Sales Value by Type (2027-2032) & (US$ Million) Table 33. Global Human Organs-on-Chips Sales Value Share by Type (2021-2026) Table 34. Global Human Organs-on-Chips Sales Value Share by Type (2027-2032) Table 35. Significant Companies of Pharmaceutical & Biotechnology Companies Table 36. Significant Companies of Academic & Research Institutes Table 37. Significant Companies of Cosmetics Industry Table 38. Significant Companies of Others Table 39. Global Human Organs-on-Chips Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Human Organs-on-Chips Sales Volume by Application (2021-2026) & (K Units) Table 41. Global Human Organs-on-Chips Sales Volume by Application (2027-2032) & (K Units) Table 42. Global Human Organs-on-Chips Sales Volume Share by Application (2021-2026) Table 43. Global Human Organs-on-Chips Sales Volume Share by Application (2027-2032) Table 44. Global Human Organs-on-Chips Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Human Organs-on-Chips Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Human Organs-on-Chips Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Human Organs-on-Chips Sales Value Share by Application (2021-2026) Table 48. Global Human Organs-on-Chips Sales Value Share by Application (2027-2032) Table 49. Global Human Organs-on-Chips Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 50. Global Human Organs-on-Chips Sales by Region (2021-2026) & (K Units) Table 51. Global Human Organs-on-Chips Sales Market Share by Region (2021-2026) Table 52. Global Human Organs-on-Chips Sales by Region (2027-2032) & (K Units) Table 53. Global Human Organs-on-Chips Sales Market Share by Region (2027-2032) Table 54. Global Human Organs-on-Chips Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Human Organs-on-Chips Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Human Organs-on-Chips Sales Value Share by Region (2021-2026) Table 57. Global Human Organs-on-Chips Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Human Organs-on-Chips Sales Value Share by Region (2027-2032) Table 59. Global Human Organs-on-Chips Market Average Price (US$/Unit) by Region (2021-2026) Table 60. Global Human Organs-on-Chips Market Average Price (US$/Unit) by Region (2027-2032) Table 61. Global Human Organs-on-Chips Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. Global Human Organs-on-Chips Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Human Organs-on-Chips Sales by Country (2021-2026) & (K Units) Table 64. Global Human Organs-on-Chips Sales Market Share by Country (2021-2026) Table 65. Global Human Organs-on-Chips Sales by Country (2027-2032) & (K Units) Table 66. Global Human Organs-on-Chips Sales Market Share by Country (2027-2032) Table 67. Global Human Organs-on-Chips Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Human Organs-on-Chips Sales Value Market Share by Country (2021-2026) Table 69. Global Human Organs-on-Chips Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Human Organs-on-Chips Sales Value Market Share by Country (2027-2032) Table 71. Emulate Company Information Table 72. Emulate Business Overview Table 73. Emulate Human Organs-on-Chips Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Emulate Human Organs-on-Chips Product Portfolio Table 75. Emulate Recent Development Table 76. TissUse Company Information Table 77. TissUse Business Overview Table 78. TissUse Human Organs-on-Chips Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. TissUse Human Organs-on-Chips Product Portfolio Table 80. TissUse Recent Development Table 81. Hesperos Company Information Table 82. Hesperos Business Overview Table 83. Hesperos Human Organs-on-Chips Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hesperos Human Organs-on-Chips Product Portfolio Table 85. Hesperos Recent Development Table 86. CN Bio Innovations Company Information Table 87. CN Bio Innovations Business Overview Table 88. CN Bio Innovations Human Organs-on-Chips Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. CN Bio Innovations Human Organs-on-Chips Product Portfolio Table 90. CN Bio Innovations Recent Development Table 91. Tara Biosystems Company Information Table 92. Tara Biosystems Business Overview Table 93. Tara Biosystems Human Organs-on-Chips Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Tara Biosystems Human Organs-on-Chips Product Portfolio Table 95. Tara Biosystems Recent Development Table 96. Draper Laboratory Company Information Table 97. Draper Laboratory Business Overview Table 98. Draper Laboratory Human Organs-on-Chips Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Draper Laboratory Human Organs-on-Chips Product Portfolio Table 100. Draper Laboratory Recent Development Table 101. Mimetas Company Information Table 102. Mimetas Business Overview Table 103. Mimetas Human Organs-on-Chips Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Mimetas Human Organs-on-Chips Product Portfolio Table 105. Mimetas Recent Development Table 106. Nortis Company Information Table 107. Nortis Business Overview Table 108. Nortis Human Organs-on-Chips Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Nortis Human Organs-on-Chips Product Portfolio Table 110. Nortis Recent Development Table 111. Micronit Microtechnologies B.V. Company Information Table 112. Micronit Microtechnologies B.V. Business Overview Table 113. Micronit Microtechnologies B.V. Human Organs-on-Chips Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Micronit Microtechnologies B.V. Human Organs-on-Chips Product Portfolio Table 115. Micronit Microtechnologies B.V. Recent Development Table 116. Kirkstall Company Information Table 117. Kirkstall Business Overview Table 118. Kirkstall Human Organs-on-Chips Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Kirkstall Human Organs-on-Chips Product Portfolio Table 120. Kirkstall Recent Development Table 121. Cherry Biotech SAS Company Information Table 122. Cherry Biotech SAS Business Overview Table 123. Cherry Biotech SAS Human Organs-on-Chips Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Cherry Biotech SAS Human Organs-on-Chips Product Portfolio Table 125. Cherry Biotech SAS Recent Development Table 126. Else Kooi Laboratory Company Information Table 127. Else Kooi Laboratory Business Overview Table 128. Else Kooi Laboratory Human Organs-on-Chips Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Else Kooi Laboratory Human Organs-on-Chips Product Portfolio Table 130. Else Kooi Laboratory Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Human Organs-on-Chips Distributors List Table 134. Human Organs-on-Chips Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Human Organs-on-Chips Product Image Figure 2. Global Human Organs-on-Chips Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Organs-on-Chips Sales Value (2021-2032) & (US$ Million) Figure 4. Global Human Organs-on-Chips Sales (2021-2032) & (K Units) Figure 5. Global Human Organs-on-Chips Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Human Organs-on-Chips Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Brain-on-a-chip Image Figure 10. Liver-on-a-chip Image Figure 11. Kidney-on-a-chip Image Figure 12. Lung-on-a-chip Image Figure 13. Heart-on-a-chip Image Figure 14. Intestine-on-a-chip Image Figure 15. Vessel-on-a-chip Image Figure 16. Other Organs Image Figure 17. Global Human Organs-on-Chips Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Human Organs-on-Chips Sales Volume Share 2021 VS 2025 VS 2032 Figure 19. Global Human Organs-on-Chips Sales Volume Share by Type (2021-2032) Figure 20. Global Human Organs-on-Chips Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Human Organs-on-Chips Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Human Organs-on-Chips Sales Value Share by Type (2021-2032) Figure 23. Pharmaceutical & Biotechnology Companies Image Figure 24. Academic & Research Institutes Image Figure 25. Cosmetics Industry Image Figure 26. Others Image Figure 27. Global Human Organs-on-Chips Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Human Organs-on-Chips Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Human Organs-on-Chips Sales Volume Share by Application (2021-2032) Figure 30. Global Human Organs-on-Chips Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Human Organs-on-Chips Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Human Organs-on-Chips Sales Value Share by Application (2021-2032) Figure 33. Global Human Organs-on-Chips Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 34. Global Human Organs-on-Chips Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Human Organs-on-Chips Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Human Organs-on-Chips Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Human Organs-on-Chips Sales Value (2021-2032) & (US$ Million) Figure 38. North America Human Organs-on-Chips Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Human Organs-on-Chips Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Human Organs-on-Chips Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Human Organs-on-Chips Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Human Organs-on-Chips Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Human Organs-on-Chips Sales Value (2021-2032) & (US$ Million) Figure 44. South America Human Organs-on-Chips Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Human Organs-on-Chips Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Human Organs-on-Chips Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Human Organs-on-Chips Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Human Organs-on-Chips Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Human Organs-on-Chips Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • Brain-on-a-chip
  • Liver-on-a-chip
  • Kidney-on-a-chip
  • Lung-on-a-chip
  • Heart-on-a-chip
  • Intestine-on-a-chip
  • Vessel-on-a-chip
  • Other Organs
Applications
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Cosmetics Industry
  • Others
Companies covered
  • Emulate
  • TissUse
  • Hesperos
  • CN Bio Innovations
  • Tara Biosystems
  • Draper Laboratory
  • Mimetas
  • Nortis
  • Micronit Microtechnologies B.V.
  • Kirkstall
  • Cherry Biotech SAS
  • Else Kooi Laboratory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Organs-on-Chips Sales Value (2021-2032)
  4. 1.2.2 Global Human Organs-on-Chips Sales Volume (2021-2032)
  5. 1.2.3 Global Human Organs-on-Chips Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Human Organs-on-Chips Market Dynamics
  1. 2.1 Human Organs-on-Chips Industry Trends
  2. 2.2 Human Organs-on-Chips Industry Drivers
  3. 2.3 Human Organs-on-Chips Industry Opportunities and Challenges
  4. 2.4 Human Organs-on-Chips Industry Restraints
3 Human Organs-on-Chips Market by Company
  1. 3.1 Global Human Organs-on-Chips Company Revenue Ranking in 2025
  2. 3.2 Global Human Organs-on-Chips Revenue by Company (2021-2026)
  3. 3.3 Global Human Organs-on-Chips Sales Volume by Company (2021-2026)
  4. 3.4 Global Human Organs-on-Chips Average Price by Company (2021-2026)
  5. 3.5 Global Human Organs-on-Chips Company Ranking (2024-2026)
  6. 3.6 Global Human Organs-on-Chips Company Manufacturing Base and Headquarters
  7. 3.7 Global Human Organs-on-Chips Company Product Type and Application
  8. 3.8 Global Human Organs-on-Chips Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Human Organs-on-Chips Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Human Organs-on-Chips Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Human Organs-on-Chips Market by Type
  1. 4.1 Human Organs-on-Chips Type Introduction
  2. 4.1.1 Brain-on-a-chip
  3. 4.1.2 Liver-on-a-chip
  4. 4.1.3 Kidney-on-a-chip
  5. 4.1.4 Lung-on-a-chip
  6. 4.1.5 Heart-on-a-chip
  7. 4.1.6 Intestine-on-a-chip
  8. 4.1.7 Vessel-on-a-chip
  9. 4.1.8 Other Organs
  10. 4.2 Global Human Organs-on-Chips Sales Volume by Type
  11. 4.2.1 Global Human Organs-on-Chips Sales Volume by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Human Organs-on-Chips Sales Volume by Type (2021-2032)
  13. 4.2.3 Global Human Organs-on-Chips Sales Volume Share by Type (2021-2032)
  14. 4.3 Global Human Organs-on-Chips Sales Value by Type
  15. 4.3.1 Global Human Organs-on-Chips Sales Value by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Human Organs-on-Chips Sales Value by Type (2021-2032)
  17. 4.3.3 Global Human Organs-on-Chips Sales Value Share by Type (2021-2032)
5 Human Organs-on-Chips Market by Application
  1. 5.1 Human Organs-on-Chips Application Introduction
  2. 5.1.1 Pharmaceutical & Biotechnology Companies
  3. 5.1.2 Academic & Research Institutes
  4. 5.1.3 Cosmetics Industry
  5. 5.1.4 Others
  6. 5.2 Global Human Organs-on-Chips Sales Volume by Application
  7. 5.2.1 Global Human Organs-on-Chips Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Human Organs-on-Chips Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Human Organs-on-Chips Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Human Organs-on-Chips Sales Value by Application
  11. 5.3.1 Global Human Organs-on-Chips Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Human Organs-on-Chips Sales Value by Application (2021-2032)
  13. 5.3.3 Global Human Organs-on-Chips Sales Value Share by Application (2021-2032)
6 Human Organs-on-Chips Regional Sales and Value Analysis
  1. 6.1 Global Human Organs-on-Chips Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Organs-on-Chips Sales by Region (2021-2032)
  3. 6.2.1 Global Human Organs-on-Chips Sales by Region: 2021-2026
  4. 6.2.2 Global Human Organs-on-Chips Sales by Region (2027-2032)
  5. 6.3 Global Human Organs-on-Chips Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Human Organs-on-Chips Sales Value by Region (2021-2032)
  7. 6.4.1 Global Human Organs-on-Chips Sales Value by Region: 2021-2026
  8. 6.4.2 Global Human Organs-on-Chips Sales Value by Region (2027-2032)
  9. 6.5 Global Human Organs-on-Chips Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Human Organs-on-Chips Sales Value (2021-2032)
  12. 6.6.2 North America Human Organs-on-Chips Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Human Organs-on-Chips Sales Value (2021-2032)
  15. 6.7.2 Europe Human Organs-on-Chips Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Human Organs-on-Chips Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Human Organs-on-Chips Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Human Organs-on-Chips Sales Value (2021-2032)
  21. 6.9.2 South America Human Organs-on-Chips Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Human Organs-on-Chips Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Human Organs-on-Chips Sales Value Share by Country, 2025 VS 2032
7 Human Organs-on-Chips Country-level Sales and Value Analysis
  1. 7.1 Global Human Organs-on-Chips Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Human Organs-on-Chips Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Human Organs-on-Chips Sales by Country (2021-2032)
  4. 7.3.1 Global Human Organs-on-Chips Sales by Country (2021-2026)
  5. 7.3.2 Global Human Organs-on-Chips Sales by Country (2027-2032)
  6. 7.4 Global Human Organs-on-Chips Sales Value by Country (2021-2032)
  7. 7.4.1 Global Human Organs-on-Chips Sales Value by Country (2021-2026)
  8. 7.4.2 Global Human Organs-on-Chips Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Human Organs-on-Chips Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Human Organs-on-Chips Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Human Organs-on-Chips Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Emulate
  2. 8.1.1 Emulate Company Information
  3. 8.1.2 Emulate Business Overview
  4. 8.1.3 Emulate Human Organs-on-Chips Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Emulate Human Organs-on-Chips Product Portfolio
  6. 8.1.5 Emulate Recent Developments
  7. 8.2 TissUse
  8. 8.2.1 TissUse Company Information
  9. 8.2.2 TissUse Business Overview
  10. 8.2.3 TissUse Human Organs-on-Chips Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 TissUse Human Organs-on-Chips Product Portfolio
  12. 8.2.5 TissUse Recent Developments
  13. 8.3 Hesperos
  14. 8.3.1 Hesperos Company Information
  15. 8.3.2 Hesperos Business Overview
  16. 8.3.3 Hesperos Human Organs-on-Chips Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hesperos Human Organs-on-Chips Product Portfolio
  18. 8.3.5 Hesperos Recent Developments
  19. 8.4 CN Bio Innovations
  20. 8.4.1 CN Bio Innovations Company Information
  21. 8.4.2 CN Bio Innovations Business Overview
  22. 8.4.3 CN Bio Innovations Human Organs-on-Chips Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CN Bio Innovations Human Organs-on-Chips Product Portfolio
  24. 8.4.5 CN Bio Innovations Recent Developments
  25. 8.5 Tara Biosystems
  26. 8.5.1 Tara Biosystems Company Information
  27. 8.5.2 Tara Biosystems Business Overview
  28. 8.5.3 Tara Biosystems Human Organs-on-Chips Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Tara Biosystems Human Organs-on-Chips Product Portfolio
  30. 8.5.5 Tara Biosystems Recent Developments
  31. 8.6 Draper Laboratory
  32. 8.6.1 Draper Laboratory Company Information
  33. 8.6.2 Draper Laboratory Business Overview
  34. 8.6.3 Draper Laboratory Human Organs-on-Chips Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Draper Laboratory Human Organs-on-Chips Product Portfolio
  36. 8.6.5 Draper Laboratory Recent Developments
  37. 8.7 Mimetas
  38. 8.7.1 Mimetas Company Information
  39. 8.7.2 Mimetas Business Overview
  40. 8.7.3 Mimetas Human Organs-on-Chips Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mimetas Human Organs-on-Chips Product Portfolio
  42. 8.7.5 Mimetas Recent Developments
  43. 8.8 Nortis
  44. 8.8.1 Nortis Company Information
  45. 8.8.2 Nortis Business Overview
  46. 8.8.3 Nortis Human Organs-on-Chips Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nortis Human Organs-on-Chips Product Portfolio
  48. 8.8.5 Nortis Recent Developments
  49. 8.9 Micronit Microtechnologies B.V.
  50. 8.9.1 Micronit Microtechnologies B.V. Company Information
  51. 8.9.2 Micronit Microtechnologies B.V. Business Overview
  52. 8.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Micronit Microtechnologies B.V. Human Organs-on-Chips Product Portfolio
  54. 8.9.5 Micronit Microtechnologies B.V. Recent Developments
  55. 8.10 Kirkstall
  56. 8.10.1 Kirkstall Company Information
  57. 8.10.2 Kirkstall Business Overview
  58. 8.10.3 Kirkstall Human Organs-on-Chips Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Kirkstall Human Organs-on-Chips Product Portfolio
  60. 8.10.5 Kirkstall Recent Developments
  61. 8.11 Cherry Biotech SAS
  62. 8.11.1 Cherry Biotech SAS Company Information
  63. 8.11.2 Cherry Biotech SAS Business Overview
  64. 8.11.3 Cherry Biotech SAS Human Organs-on-Chips Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Cherry Biotech SAS Human Organs-on-Chips Product Portfolio
  66. 8.11.5 Cherry Biotech SAS Recent Developments
  67. 8.12 Else Kooi Laboratory
  68. 8.12.1 Else Kooi Laboratory Company Information
  69. 8.12.2 Else Kooi Laboratory Business Overview
  70. 8.12.3 Else Kooi Laboratory Human Organs-on-Chips Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Else Kooi Laboratory Human Organs-on-Chips Product Portfolio
  72. 8.12.5 Else Kooi Laboratory Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Organs-on-Chips Value Chain Analysis
  2. 9.1.1 Human Organs-on-Chips Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Organs-on-Chips Sales Mode & Process
  6. 9.2 Human Organs-on-Chips Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Organs-on-Chips Distributors
  9. 9.2.3 Human Organs-on-Chips Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst